Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
The EU needs to address the increasing problem of environmental pollution due to pharmaceuticals throughout their life cycle. This topic is part of an EU strategic approach to pharmaceuticals in the environment and the Pharmaceutical strategy for Europe called for diversifying and secure supply chains and environmentally sustainable pharmaceuticals.
The purpose of this topic is twofold.
The Purposes:
Applicants should propose activities linked to several of the following elements:
Projects should integrate at the same time the academic and public health perspective.
Proposals could consider the involvement of the European Commission’s Joint Research Centre (JRC) in the field of new approach methodologies for ecotoxicity assessment.
100%
Contribution per project: € 8,00 million
The Joint Research Centre (JRC) may participate as member of the consortium selected for funding.
Research and Innovation Foundation
Strovolos Avenue 123, 2042 Nicosia, Cyprus, P.O.Box 23422, 1683 Nicosia
Email: support@research.org.cy
Website: https://www.research.org.cy/
Dr Angelos Ntantos
Scientific Officer
Telephone: 35722205033
Email: antantos@research.org.cy
Dr Ioannis Theodorou
Scientific Officer
Telephone: 35722205038
Email: itheodorou@research.org.cy
(Publish Date: 05/08/2021-for internal use only)